Cramer’s Investing Club Stock Profile: Drugmaker Abbvie deserves a lot more love from the market

Cramer’s Investing Club: We’re adding to our position in this drugmaker on weaknessInvesting Club: We’re starting a new position in this energy name, buying more of a bankMonday, Jan. 24: Jim Cramer discusses what he’s buying in the oversold market